Activity delivery progress monitor

摘要

A system and method for monitoring progress of a radiopharmaceutical injection procedure includes: measuring and monitoring radiopharmaceutical activity of a radiopharmaceutical remaining in at least a portion of a disposable administration set used with a radiopharmaceutical fluid delivery system; and displaying the radiopharmaceutical activity remaining in at least the portion of the disposable administration set to an operator.

主权项

1. A method for monitoring progress of a radiopharmaceutical injection procedure comprising:
measuring and monitoring a radiopharmaceutical activity of a radiopharmaceutical remaining in a portion of a disposable administration set used with a radiopharmaceutical fluid delivery device, wherein the measuring and monitoring are performed continuously during the radiopharmaceutical injection procedure as the radiopharmaceutical is being injected into a patient; displaying the radiopharmaceutical activity of the radiopharmaceutical remaining in the portion of the disposable administration set, wherein the displaying is performed during the radiopharmaceutical injection procedure as the radiopharmaceutical is being injected into the patient; detecting whether the radiopharmaceutical activity of the radiopharmaceutical remaining in the portion of the disposable administration set differs from an expected value of radiopharmaceutical activity remaining in the portion of the disposable administration set at a given time during the radiopharmaceutical injection procedure as the radiopharmaceutical is being injected into the patient; determining that the radiopharmaceutical activity of the radiopharmaceutical remaining in the portion of the disposable administration set differs from the expected value of radiopharmaceutical activity remaining in the portion of the disposable administration set at the given time; and determining that a delivery issue has occurred during the radiopharmaceutical injection procedure as the radiopharmaceutical is being injected into the patient based on the determination that the radiopharmaceutical activity of the radiopharmaceutical remaining in the portion of the disposable administration set differs from the expected value.